Promising Results for Alzheimer’s Treatment by Anavex Life Sciences

On September 15, 2023, groundbreaking data from a phase 2b/3 clinical trial revealed that the investigational medication blarcamesine, developed by Anavex Life Sciences, significantly reduces amyloid-ß biomarkers in patients with early Alzheimer’s disease. The findings were made public by Anavex Life Sciences, highlighting the potential of blarcamesine to alter the course of this debilitating condition.  […]

Tieks: A Blend of Style and Social Impact Under Kfir Gavrieli’s Leadership

In the competitive landscape of fashion, Tieks has distinguished itself not just through its stylish product offerings but also via its significant social contributions. Spearheaded by CEO Kfir Gavrieli, the brand has managed to successfully intertwine commercial success with philanthropy.  Tieks, known for its versatile and comfortable ballet flats, has garnered a dedicated customer base […]